| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |